Aelis Farma secures EUR458k France 2030 grant to advance metabolic disease programme

Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency

NeuroSense's PrimeC composition receives Brazilian patent

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development

Alltrna granted approval for first-in-human clinical trial of AP003

Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share

Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management

AstraZeneca reports positive phase III results for efzimfotase alfa in hypophosphatasia

Galapagos and Gilead expand collaboration to advance T cell engager programme

Sanofi secures EU approval for Rezurock in chronic graft-versus-host disease